Follow-up of children exposed to perinatal antiretrovirals.
Fowler
M G
MG
MCTPASS/Epidemiology Branch, Division of HIV/AIDS-SE, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
D000740:Anemia / Q000139:chemically induced; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000633:toxicity*; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000633:toxicity; D015215:Zidovudine / Q000009:adverse effects / Q000633:toxicity
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine